Ahrens Investment Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-485
Closed -$16K 813
2022
Q2
$16K Buy
485
+5
+1% +$212 0.01% 553
2022
Q1
$35K Buy
480
+25
+5% +$1.8K 0.01% 470
2021
Q4
$42K Buy
+455
New +$54.4K 0.02% 440
2018
Q4
Sell
-4,025
Closed -$348K 192
2018
Q3
$348K Buy
4,025
+150
+4% +$10.7K 0.13% 110
2018
Q2
$225K Buy
+3,875
New +$189K 0.09% 141

Other funds holding TDOC

Ahrens Investment Partners's TDOC Position: Q3 2022 in Review

Ahrens Investment Partners sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 485 shares — an estimated $16K sold.

Ahrens Investment Partners first reported a position in TDOC in Q2 2018 and held it in 5 quarters. The position peaked at $348K in Q3 2018. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Ahrens Investment Partners reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 485 Teladoc Health shares in Q3 2022, an estimated $16K.
  • Ahrens Investment Partners first reported a position in Teladoc Health in Q2 2018 and held it in 5 quarters.
  • Ahrens Investment Partners's Teladoc Health position peaked at $348K in Q3 2018.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Ahrens Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.